BillionToOne, Inc. (BLLN) vs Sotera Health Company (SHC)

BillionToOne, Inc. and Sotera Health Company are both Diagnostics & Research companies. BillionToOne, Inc. and Sotera Health Company are of similar size ($5.2B and $4.9B). Sotera Health Company trades at the lower P/E: 31.4× against 95.0×. Sotera Health Company has the higher net margin (13.4% vs 8.35%) and the lower return on invested capital (9.82% vs 34.1%). Across the 19 metrics below, Sotera Health Company leads on 12 and BillionToOne, Inc. on 7.

Valuation

Metric BLLN SHC Diagnostics & Research median
P/E 94.98 31.39 35.56
P/S 11.45 4.20 4.37
P/B 8.48 7.68 3.06
Price to free cash flow 137.17 45.36 35.76
EV/EBITDA 73.61 13.18 24.35
EV/Sales 10.30 5.74 5.51
Earnings yield 1.05% 3.19% (1.89%)
Free cash flow yield 0.73% 2.20% (0.15%)

Profitability

Metric BLLN SHC Diagnostics & Research median
Gross margin 71.27% 54.97% 50.89%
Operating margin 10.90% 32.82% (8.57%)
Net margin 8.35% 13.44% (6.37%)
Free cash flow margin 8.35% 9.27% 0.00%
Return on equity 23.27% 27.78% (2.92%)
Return on assets 9.09% 5.01% (6.71%)
Return on invested capital 34.10% 9.82% 0.00%

Growth

Metric BLLN SHC Diagnostics & Research median
Revenue growth (TTM) — 8.15% 7.69%
EPS growth (last fiscal year) 103.40% 68.75% 25.92%
Revenue growth, 5-year CAGR — 7.30% 7.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric BLLN SHC Diagnostics & Research median
Debt to equity 0.17 3.35 0.11
Current ratio 11.69 2.80 2.02
Net debt to EBITDA (15.70) 3.74 0.70

Dividend

Metric BLLN SHC Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric BLLN SHC Diagnostics & Research median
Market cap 4.85b 5.16b 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack